Over 10% of cardiology practice patients inappropriately take aspirin
the ONA take:
According to a new study published in the Journal of the American College of Cardiology, researchers from Michael E. DeBakey Veterans Affairs Medical Center in Houston, Texas, have found that more than 10% of patients are inappropriately taking aspirin for primary prevention of cardiovascular disease.
For the study, researchers identified over 254,000 patients who were taking aspirin between 2008 and 2013 from the National Cardiovascular Disease Registry Practice Innovation and Clinical Experience (PINNACLE) registry. The researchers used the Framingham risk calculator to assess the 10-year risk of cardiovascular disease of the 68,808 evaluable patients.
The researchers defined inappropriate aspirin use for primary prevention as taking aspirin when a patient's 10-year risk was less than 6%; some guidelines say inappropriate use is less than a 10% risk. Results showed that 11.6% of patients taking aspirin for primary prevention had a 10-year risk of less than 6%.
In addition, when comparing inappropriate aspirin use among different cardiology practices, researchers found that inappropriate use ranged from 0% to 70% in different practices.
The findings suggest that the 10-year cardiovascular disease risk should be calculated for each patient, and the clinician should discuss the risk versus benefit of aspirin use with that patient.
More than 10% of patients are inappropriately taking aspirin for primary prevention of cardiovascular disease.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|